MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Coping with Parkinson’s Disease through the Lens of Personality Systems Interactions (PSI) Theory: Two Case Studies

    E. Wünnenberg, N. Baumann (Trier, Germany)

    Objective: This study examines how concepts from motivation and personality research contribute to understanding coping strategies in individuals with Parkinson’s disease (PD). Background: Effective treatment…
  • 2025 International Congress

    Dietary Caffeic Acid Exhibits Neuroprotective and Neuromodulatory Effects in a Parkinsonian Rat Model by Mitigating Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis

    A. Singh (Prayagraj, India)

    Objective: This study investigated the neuroprotective and neuromodulatory effects of dietary caffeic acid (CA) in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonian rat model Background: Parkinson’s disease (PD)…
  • 2025 International Congress

    The Impact of Statin Therapy on Motor and Non-Motor Symptoms in Parkinson’s Disease: A Meta-Analysis

    V. Byroju, J. Pitton Rissardo, A. Fornari Caprara (Camden, USA)

    Objective: To assess the effects of statin therapy on motor and non-motor symptoms in Parkinson’s disease (PD) through a meta-analysis of randomized controlled trials. Background:…
  • 2025 International Congress

    Trihexyphenidyl as a Treatment for Severe Freezing of Gait in Parkinson’s Disease: A Case Report

    J. Ha, M. Ferris (Palo Alto, USA)

    Objective: To present a unique case in which trihexyphenidyl was used as an effective treatment to dramatically reduce freezing of gait (FoG) in a Parkinson’s…
  • 2025 International Congress

    Intravenous L-dopa Administration in PD and DLB Patients with Oral Intake Difficulties: Current Status and Challenges

    S. Nishida (Tokai, Japan)

    Objective: Investigation of efficacy and challenges of intravenous L-dopa therapy as an alternative treatment for PD patients and those with DLB who experience difficulty with…
  • 2025 International Congress

    Inpatient Multimodal Care Improves Parkinsonian Symptoms Regardless Of Race Or Ethnicity

    N. Elayan, L. Rubin, M. Mccrossin, A. Di Rocco, M. Ghilardi (New York, USA)

    Objective: To verify demographic characteristics of patients with Parkinson’s disease (PD) completing a two-week inpatient multimodal intensive neurorehabilitation and care (iMINC) program and whether iMINC…
  • 2025 International Congress

    Fecal Microbiota Transplantation for Parkinson’s Disease: A Systematic Review and Meta-Analysis

    A. Menegaz Ms, J. Martinez-Lemus Md, í. Barros Andrade, F. Tamashiro Ms, F. Westphal Filho, P. Moss Ms, J. Patiño Md, M. Schiess Md (Houston, USA)

    Objective: To assess Fecal Microbiota Transplantation (FMT) efficacy in improving Parkinson’s disease (PD) symptoms. Background: Dysregulation of the microbiome–gut–brain axis is a key pathophysiological mechanism…
  • 2025 International Congress

    Predicting Parkinson’s disease severity and cognitive decline using blood-based ferroptotic biomarkers

    V. Huin, E. Cailliau, G. Garçon, M. Dutheil, O. Simonin, N. Beauval, J. Labreuche, D. Blum, C. Moreau, E. Hainque, A. Marques, A. Eusebio, I. Benatru, C. Brefel-Courbon, D. Maltete, C. Giordana, M. Tir, S. Thobois, JP. Brandel, B. Jarraya, L. Hopes, O. Rascol, JC. Corvol, D. Devos, AS. Rolland (Lille, France)

    Objective: As Parkinson’s disease progresses, patients require second-line treatments such as subthalamic stimulation, the benefits of which may be undermined by the appearance of non-dopaminergic…
  • 2025 International Congress

    Diagnostic accuracy and clinical correlates of real-time quaking-induced conversion assay on gastric biopsy in early Parkinson’s disease

    C. Shin, JP. Im, JY. Han, B. Jin, KA. Woo, S. Lee, HY. Jeon, JY. Joo, HJ. Chang, JH. Shin, HJ. Kim, JM. Kim, YP. Choi, B. Jeon (Seoul, Republic of Korea)

    Objective: To evaluate the utility of the real-time quaking-induced conversion (RT-QuIC) assay in stomach biopsies as a biomarker for early Parkinson’s disease (PD) and to…
  • 2025 International Congress

    Balance biomarker for early differentiation of Parkinson’s disease and multiple system atrophy with parkinsonian type

    HJ. Chang, JH. Kim, S. Lee, E. Kwon, SH. Jeong, E. Oh (Daejeon, Republic of Korea)

    Objective: We propose a random forest model utilizing balance analysis to differentiate early-stage Parkinson’s disease (PD) and multiple system atrophy with parkinsonian type (MSA-P) patients.…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley